Ra Medical Systems, Inc. (RMED)

NYSEAMERICAN: RMED · IEX Real-Time Price · USD
0.181
+0.007 (4.03%)
At close: Aug 11, 2022 4:00 PM
0.192
+0.011 (6.136%)
Pre-market: Aug 12, 2022 8:37 AM EDT
4.03%
Market Cap 5.84M
Revenue (ttm) 1.02M
Net Income (ttm) -23.33M
Shares Out 32.30M
EPS (ttm) -2.50
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,153,047
Open 0.179
Previous Close 0.174
Day's Range 0.175 - 0.195
52-Week Range 0.150 - 3.650
Beta 1.09
Analysts Buy
Price Target 6.68 (+3,592.6%)
Earnings Date Aug 15, 2022

About RMED

Ra Medical Systems, Inc., a medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular immune-mediated inflammatory diseases. It offers destruction of arteriosclerotic blockages by laser radiation ablation, a minimally invasive excimer laser and single-use catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. The company sells its products primarily through distributors in the United States. Ra Medical S... [Read more...]

Industry Health Care Equipment & Supplies
IPO Date Aug 30, 2018
Employees 58
Stock Exchange NYSEAMERICAN
Ticker Symbol RMED
Full Company Profile

Financial Performance

In 2021, RMED's revenue was $22,000, a decrease of -91.51% compared to the previous year's $259,000. Losses were -$25.07 million, -30.45% less than in 2020.

Financial Statements

Analyst Forecast

According to 8 analysts, the average rating for RMED stock is "Buy." The 12-month stock price forecast is 6.68, which is an increase of 3,592.65% from the latest price.

Price Target
$6.68
(3,592.65% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Ra Medical Systems Provides Update on its Annual Filings

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company) announces that its audited consolidated financial statements for the fiscal year ended De...

Ra Medical Systems Enters Into Agreements to Raise $6.2 Million Through Previously Issued Warrants and Plans Strategi...

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company) announces a reduction in the exercise price of all existing warrants that were issued in ...

Ra Medical Systems Appoints Brian D. Conn Interim Chief Financial Officer

CARLSBAD, Calif.--(BUSINESS WIRE)---- $RMED #Atherectomy--Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company”), a medical device company focusing on developing its excimer lase...

Why Is Ra Medical (RMED) Stock Up 65% Today?

Ra Medical (RMED) stock is rocketing higher on Tuesday after the medical device company got an update from the FDA for its new catheter. The post Why Is Ra Medical (RMED) Stock Up 65% Today?

Why Ra Medical Systems Shares Are Trading Higher Today?

The FDA has cleared RA Medical Systems Inc's (NYSE: RMED) DABRA 2.0 catheter as part of the DABRA Excimer Laser System.  This next-generation DABRA catheter features enhancements, including a braided ov...

Ra Medical Systems Receives FDA 510(k) Clearance for the DABRA 2.0 Catheter

CARLSBAD, Calif.--(BUSINESS WIRE)---- $RMED #Atherectomy--Ra Medical Systems receives FDA clearance for DABRA 2.0 catheter.

Ra Medical Systems Reports First Quarter 2022 Financial Results

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or “the Company”), a medical device company focusing on developing its excimer laser system to treat vascu...

Ra Medical Systems to Report First Quarter 2022 Financial Results on May 16, 2022

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED) announces that it will report financial results for the three months ended March 31, 2022 after market close on Monday, ...

Ra Medical Systems Granted U.S. Patent for Laser Ablation Catheters with Expanded Ablation Area

CARLSBAD, Calif.--(BUSINESS WIRE)---- $RMED--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on developing its excimer laser system to treat vascular diseases, announce...

Ra Medical Systems Achieves Milestone of 100 Subjects Enrolled in its Pivotal Atherectomy Clinical Study

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on developing its excimer laser system to treat vascular diseases, announces the achi...

Ra Medical Systems Reports 2021 Fourth Quarter and Full Year Financial Results

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on developing its excimer laser system to treat vascular disease, reports financial r...

Ra Medical Systems to Report 2021 Fourth Quarter and Full Year Financial Results on March 23, 2022

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED) announces that it will report 2021 fourth quarter and full year financial results after market close on Wednesday, March...

Ra Medical Systems Files 510(k) Application for the DABRA Catheter with Braided Overjacket and Six-Month Shelf Life

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on developing its excimer laser system to treat vascular diseases, announces the fili...

Ra Medical Systems Provides an Update on Enrollment in Its Pivotal Atherectomy Clinical Trial

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focused on developing its excimer laser system to treat vascular diseases, announces enrollmen...

Ra Medical Systems Granted U.S. Patent for a Support Catheter for use Supporting a Liquid Core Ablation Catheter

CARLSBAD, Calif.--(BUSINESS WIRE)---- $RMED #PAD--Ra Medical Systems awarded U.S. patent for support catheter for use supporting a liquid core ablation catheter

Ra Medical Systems, Inc. Announces Closing of $12.1 Million Underwritten Public Offering

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on developing its excimer laser system to treat vascular diseases, today announced th...

Why Are Ra Medical Shares Plunging to 52-Week Low?

Ra Medical Systems Inc  RMED has priced an underwritten public offering of 9.535 million units at $0.50 per unit for approximately $12.0 million in gross proceeds. Get the Inside Access Traders Are Usin...

Ra Medical Systems, Inc. Announces Pricing of $12.0 Million Underwritten Public Offering

CARLSBAD, Calif.--(BUSINESS WIRE)---- $RMED--Ra Medical Systems announces pricing of $12.0 million underwritten public offering

Ra Medical Systems CEO Issues Letter to Stockholders

CARLSBAD, Calif.--(BUSINESS WIRE)---- $RMED #Atherectomy--Ra Medical Systems issued Letter to Stockholders.

Ra Medical Systems Reports 2021 Third Quarter Financial Results

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on developing its excimer laser system to treat vascular disease, reports financial r...

Ra Medical Systems to Report Third Quarter 2021 Financial Results on November 15, 2021

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED) announces that it will report third quarter 2021 financial results after market close on Monday, November 15. Ra Medical...

Ra Medical Systems to Present at the Virtual H.C. Wainwright 23rd Annual Global Investment Conference

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focused on commercializing excimer laser systems to treat vascular diseases, announces that ma...

Ra Medical Systems Reports 2021 Second Quarter Financial Results

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on commercializing its excimer laser system to treat vascular disease, reports financ...

Ra Medical Systems Announces Sale of Pharos Dermatology Business

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focused on commercializing its excimer laser system to treat vascular disease, announces the s...

Other symbols: SSKN

Ra Medical Systems to Report Second Quarter 2021 Financial Results on August 16, 2021

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED) announces that it will report second quarter 2021 financial results after market close on Monday, August 16, 2021. Ra Me...